Company Filing History:
Years Active: 2006
Title: Christian Lottner: Innovator in Tumor Treatment
Introduction
Christian Lottner is a notable inventor based in Neunburg, Germany. He has made significant contributions to the field of medical science, particularly in the development of innovative compounds for tumor treatment. His work focuses on enhancing the effectiveness of therapies for both benign and malignant tumor diseases.
Latest Patents
Lottner holds a patent for "Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases." This invention relates to novel, water-soluble porphyrin platinum compounds, specifically tetraarylporphyrin platinum derivatives and hematoporphyrin platinum derivatives. These compounds exhibit high tumor selectivity and are particularly suitable for photodynamic anti-tumor therapy. He has 1 patent to his name.
Career Highlights
Christian Lottner is associated with Zentaris GmbH, where he continues to work on groundbreaking research in the field of oncology. His innovative approach to developing water-soluble compounds has the potential to revolutionize treatment methods for tumor diseases.
Collaborations
Lottner collaborates with esteemed colleagues such as Karl Christian Bart and Guenther Bernhardt. Their combined expertise contributes to the advancement of research and development in tumor therapies.
Conclusion
Christian Lottner's contributions to medical science, particularly in the area of tumor treatment, highlight his role as an influential inventor. His innovative compounds pave the way for more effective therapies, showcasing the importance of research in improving health outcomes.